262 related articles for article (PubMed ID: 7931623)
1. Intracarotid infusion of RMP-7, a bradykinin analog: a method for selective drug delivery to brain tumors.
Inamura T; Nomura T; Bartus RT; Black KL
J Neurosurg; 1994 Nov; 81(5):752-8. PubMed ID: 7931623
[TBL] [Abstract][Full Text] [Related]
2. Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7.
Matsukado K; Inamura T; Nakano S; Fukui M; Bartus RT; Black KL
Neurosurgery; 1996 Jul; 39(1):125-33; discussion 133-4. PubMed ID: 8805148
[TBL] [Abstract][Full Text] [Related]
3. Bradykinin selectively opens blood-tumor barrier in experimental brain tumors.
Inamura T; Black KL
J Cereb Blood Flow Metab; 1994 Sep; 14(5):862-70. PubMed ID: 8063881
[TBL] [Abstract][Full Text] [Related]
4. Enhanced cytokines delivery and intercellular adhesion molecule 1 (ICAM-1) expression in glioma by intracarotid infusion of bradykinin analog, RMP-7.
Nakano S; Matsukado K; Black KL
Neurol Res; 1997 Oct; 19(5):501-8. PubMed ID: 9329027
[TBL] [Abstract][Full Text] [Related]
5. Repeated, short-term ischemia augments bradykinin-mediated opening of the blood-tumor barrier in rats with RG2 glioma.
Liu Y; Hashizume K; Samoto K; Sugita M; Ningaraj N; Asotra K; Black KL
Neurol Res; 2001 Sep; 23(6):631-40. PubMed ID: 11547933
[TBL] [Abstract][Full Text] [Related]
6. Intracarotid infusion of bradykinin selectively increases blood-tumor permeability in 9L and C6 brain tumors.
Nomura T; Inamura T; Black KL
Brain Res; 1994 Oct; 659(1-2):62-6. PubMed ID: 7529648
[TBL] [Abstract][Full Text] [Related]
7. Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide.
Nakano S; Matsukado K; Black KL
Cancer Res; 1996 Sep; 56(17):4027-31. PubMed ID: 8752174
[TBL] [Abstract][Full Text] [Related]
8. Steroids decrease uptake of carboplatin in rat gliomas--uptake improved by intracarotid infusion of bradykinin analog, RMP-7.
Matsukado K; Nakano S; Bartus RT; Black KL
J Neurooncol; 1997 Sep; 34(2):131-8. PubMed ID: 9210059
[TBL] [Abstract][Full Text] [Related]
9. Cyclic GMP-specific phosphodiesterase inhibition and intracarotid bradykinin infusion enhances permeability into brain tumors.
Sugita M; Black KL
Cancer Res; 1998 Mar; 58(5):914-20. PubMed ID: 9500450
[TBL] [Abstract][Full Text] [Related]
10. Unlocking the blood-brain barrier: a role for RMP-7 in brain tumor therapy.
Elliott PJ; Hayward NJ; Huff MR; Nagle TL; Black KL; Bartus RT
Exp Neurol; 1996 Oct; 141(2):214-24. PubMed ID: 8812155
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide and cyclic GMP attenuate sensitivity of the blood-tumor barrier permeability to bradykinin.
Sugita M; Hunt GE; Liu Y; Black KL
Neurol Res; 1998 Sep; 20(6):559-63. PubMed ID: 9713849
[TBL] [Abstract][Full Text] [Related]
12. Intracarotid histamine infusion increases blood tumour permeability in RG2 glioma.
Inamura T; Nomura T; Ikezaki K; Fukui M; Pöllinger G; Black KL
Neurol Res; 1994 Apr; 16(2):125-8. PubMed ID: 7913997
[TBL] [Abstract][Full Text] [Related]
13. Intracarotid infusion of RMP-7, a bradykinin analog, and transport of gallium-68 ethylenediamine tetraacetic acid into human gliomas.
Black KL; Cloughesy T; Huang SC; Gobin YP; Zhou Y; Grous J; Nelson G; Farahani K; Hoh CK; Phelps M
J Neurosurg; 1997 Apr; 86(4):603-9. PubMed ID: 9120622
[TBL] [Abstract][Full Text] [Related]
14. Steroids decrease uptake of carboplatin in rat gliomas--uptake improved by intracarotid infusion of bradykinin analog, RMP-7.
Matsukado K; Nakano S; Bartus RT; Black KL
Acta Neurochir Suppl; 1997; 70():159-61. PubMed ID: 9416308
[TBL] [Abstract][Full Text] [Related]
15. Controlled modulation of BBB permeability using the bradykinin agonist, RMP-7.
Bartus RT; Elliott PJ; Dean RL; Hayward NJ; Nagle TL; Huff MR; Snodgrass PA; Blunt DG
Exp Neurol; 1996 Nov; 142(1):14-28. PubMed ID: 8912895
[TBL] [Abstract][Full Text] [Related]
16. Selective opening of the blood-tumor barrier by intracarotid infusion of leukotriene C4.
Black KL; King WA; Ikezaki K
J Neurosurg; 1990 Jun; 72(6):912-6. PubMed ID: 2338576
[TBL] [Abstract][Full Text] [Related]
17. Intracarotid low dose bradykinin infusion selectively increases tumor permeability through activation of bradykinin B2 receptors in malignant gliomas.
Matsukado K; Sugita M; Black KL
Brain Res; 1998 May; 792(1):10-5. PubMed ID: 9593802
[TBL] [Abstract][Full Text] [Related]
18. Leukotriene E4 selectively increase the delivery of methotrexate to the C6 gliomas in rats.
Chio CC; Lin SJ; Lin MT
J Neurooncol; 1995; 25(2):89-95. PubMed ID: 8543974
[TBL] [Abstract][Full Text] [Related]
19. Selective blood-tumor barrier disruption by leukotrienes.
Chio CC; Baba T; Black KL
J Neurosurg; 1992 Sep; 77(3):407-10. PubMed ID: 1506887
[TBL] [Abstract][Full Text] [Related]
20. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.
Bartus RT; Snodgrass P; Dean RL; Kordower JH; Emerich DF
Exp Neurol; 2000 Jan; 161(1):234-44. PubMed ID: 10683290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
